Eisai
4523.T
#1957
Rank
ยฃ5.85 B
Marketcap
ยฃ20.74
Share price
0.95%
Change (1 day)
-33.07%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): ยฃ1.80

According to Eisai's latest financial reports the company's current EPS (TTM) is ยฃ1.69. In 2022 the company made an earnings per share (EPS) of ยฃ1.24 a decrease over its 2021 EPS that were of ยฃ5.51.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ1.8045.2%
2022ยฃ1.24-77.48%
2021ยฃ5.51-41.88%
2020ยฃ9.49-0.94%
2019ยฃ9.5852.59%
2018ยฃ6.28124.17%
2017ยฃ2.80-49.42%
2016ยฃ5.5437.08%
2015ยฃ4.04-11.75%
2014ยฃ4.58-3.23%
2013ยฃ4.73-18.56%
2012ยฃ5.81-15.51%
2011ยฃ6.87-3.75%
2010ยฃ7.14-1.36%
2009ยฃ7.24